Frymoyer A - Search Results

1

Minimum effective dose of clemastine in a mouse model of preterm white matter injury.

Odell EP, Jabassini N, Schniedewind B, Pease-Raissi SE, Frymoyer A, Christians U, Green AJ, Chan JR, Ostrem BEL. Odell EP, et al. Among authors: frymoyer a. Pediatr Res. 2024 Sep;96(4):933-941. doi: 10.1038/s41390-024-03326-w. Epub 2024 Jun 28. Pediatr Res. 2024. PMID: 38942888 Free PMC article.

2

A Clinical Monitoring Approach for Early Onset Sepsis: A Community Hospital Experience.

Bain L, Sivakumar D, McCallie K, Balasundaram M, Frymoyer A. Bain L, et al. Among authors: frymoyer a. Hosp Pediatr. 2022 Jan 1;12(1):16-21. doi: 10.1542/hpeds.2021-006058. Hosp Pediatr. 2022. PMID: 34935049

3

4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.

Nagy N, Kuipers HF, Frymoyer AR, Ishak HD, Bollyky JB, Wight TN, Bollyky PL. Nagy N, et al. Front Immunol. 2015 Mar 23;6:123. doi: 10.3389/fimmu.2015.00123. eCollection 2015. Front Immunol. 2015. PMID: 25852691 Free PMC article. Review.

4

High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.

Frymoyer A, Juul SE, Massaro AN, Bammler TK, Wu YW. Frymoyer A, et al. Pediatr Res. 2017 Jun;81(6):865-872. doi: 10.1038/pr.2017.15. Epub 2017 Jan 18. Pediatr Res. 2017. PMID: 28099423 Free PMC article. Clinical Trial.

5

Early career investigator highlight.

Frymoyer A. Frymoyer A. Pediatr Res. 2017 Jun;81(6):850. doi: 10.1038/pr.2017.60. Epub 2017 May 10. Pediatr Res. 2017. PMID: 28430775 No abstract available.

6

Aminophylline for renal protection in neonatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermia.

Chock VY, Cho SH, Frymoyer A. Chock VY, et al. Among authors: frymoyer a. Pediatr Res. 2021 Mar;89(4):974-980. doi: 10.1038/s41390-020-0999-y. Epub 2020 Jun 5. Pediatr Res. 2021. PMID: 32503030 Free PMC article.

7

Theophylline dosing and pharmacokinetics for renal protection in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia.

Frymoyer A, Van Meurs KP, Drover DR, Klawitter J, Christians U, Chock VY. Frymoyer A, et al. Pediatr Res. 2020 Dec;88(6):871-877. doi: 10.1038/s41390-020-01140-8. Epub 2020 Sep 12. Pediatr Res. 2020. PMID: 32919393 Free PMC article.

8

Minimum Effective Dose of Clemastine in a Mouse Model of Preterm White Matter Injury.

Odell E, Jabassini N, Schniedewind B, Pease-Raissi SE, Frymoyer A, Christians U, Green AJ, Chan JR, Ostrem BEL. Odell E, et al. Among authors: frymoyer a. bioRxiv [Preprint]. 2024 Mar 1:2024.02.08.578953. doi: 10.1101/2024.02.08.578953. bioRxiv. 2024. Update in: Pediatr Res. 2024 Sep;96(4):933-941. doi: 10.1038/s41390-024-03326-w PMID: 38464078 Free PMC article. Updated. Preprint.

9

On target dosing: erythropoietin exposure in neonates with hypoxic-ischemic encephalopathy in the HEAL trial.

Frymoyer A, Vasconcelos AG, Juul SE, Comstock BA, Heagerty PJ, Wu YW. Frymoyer A, et al. Pediatr Res. 2024 Nov 10. doi: 10.1038/s41390-024-03709-z. Online ahead of print. Pediatr Res. 2024. PMID: 39523391

10

Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach.

Frymoyer A, Stockmann C, Hersh AL, Goswami S, Keizer RJ. Frymoyer A, et al. J Pediatric Infect Dis Soc. 2019 May 11;8(2):97-104. doi: 10.1093/jpids/pix109. J Pediatric Infect Dis Soc. 2019. PMID: 29294072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters